Page last updated: 2024-08-21

alpha-aminopyridine and Glomerulonephritis

alpha-aminopyridine has been researched along with Glomerulonephritis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhangal, G; Chawanasuntorapoj, R; Cook, HT; Masuda, ES; McDaid, JP; Pusey, CD; Smith, J; Tam, FW1
Kapoor, S1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Glomerulonephritis

ArticleYear
A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis.
    Journal of the American Society of Nephrology : JASN, 2010, Volume: 21, Issue:2

    Topics: Aminopyridines; Animals; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Glomerulonephritis; Interleukin-1beta; Intracellular Signaling Peptides and Proteins; Macrophages; Mesangial Cells; Morpholines; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats; Rats, Inbred WKY; Severity of Illness Index; Signal Transduction; Syk Kinase

2010
Comment on "Therapeutic targeting of Syk in autoimmune diabetes".
    Journal of immunology (Baltimore, Md. : 1950), 2011, Feb-15, Volume: 186, Issue:4

    Topics: Aminopyridines; Autoimmune Diseases; Diabetes Mellitus, Type 2; Glomerulonephritis; Humans; Intracellular Signaling Peptides and Proteins; Morpholines; Oxazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Reperfusion Injury; Signal Transduction; Spleen; Syk Kinase

2011